ABP
GILD icon

Arthur B. Page’s Gilead Sciences GILD Stock Holding History

Arthur B. Page’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,945
Closed -$305K – 62
2018
Q3 		$305K Sell
3,945
-7,505
-66% -$567K 0.26% 57
2018
Q2 		$812K Sell
11,450
-825
-7% -$58.3K 0.74% 38
2018
Q1 		$927K Hold
12,275
– – 0.84% 37
2017
Q4 		$880K Buy
12,275
+230
+2% +$17.5K 0.77% 38
2017
Q3 		$976K Sell
12,045
-1,020
-8% -$78K 0.86% 35
2017
Q2 		$926K Sell
13,065
-270
-2% -$18K 0.81% 38
2017
Q1 		$905K Sell
13,335
-20
-0.1% -$1.41K 0.81% 38
2016
Q4 		$957K Buy
13,355
+715
+6% +$53.1K 0.91% 35
2016
Q3 		$1M Buy
12,640
+3,415
+37% +$277K 0.98% 35
2016
Q2 		$769K Buy
9,225
+5,361
+139% +$476K 0.77% 40
2016
Q1 		$355K Buy
+3,864
New +$348K 0.36% 55

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arthur B. Page's GILD Position: Q4 2018 in Review

Arthur B. Page sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,945 shares — an estimated $305K sold.

Arthur B. Page first reported a position in GILD in Q1 2016 and held it in 11 quarters. The position peaked at $1M in Q3 2016. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Arthur B. Page reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Arthur B. Page sold 3,945 Gilead Sciences shares in Q4 2018, an estimated $305K.
  • Arthur B. Page first reported a position in Gilead Sciences in Q1 2016 and held it in 11 quarters.
  • Arthur B. Page's Gilead Sciences position peaked at $1M in Q3 2016.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Arthur B. Page's 13F filing for Q4 2018, filed 24 Jan 2019.